Microbot Medical Inc buy The Goldman Sachs Group, Inc.
Start price
24.01.24
/
50%
€1.17
Target price
24.01.25
€5.51
Performance (%)
-23.72%
Price
06.05.24
€0.89
Summary
This prediction is currently active. The price of Microbot Medical Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -23.72%. This prediction currently runs until 24.01.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Microbot Medical Inc | 10.801% | 10.801% |
iShares Core DAX® | 0.476% | -0.039% |
iShares Nasdaq 100 | 1.290% | 0.504% |
iShares Nikkei 225® | 1.300% | -2.135% |
iShares S&P 500 | 0.829% | 0.193% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Microbot Medical Inc diskutieren
Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $7.00 to $6.00. They now have a "buy" rating on the stock.
Ratings data for STEM provided by MarketBeat